Aptevo Therapeutics effects 1-for-20 reverse stock split effective May 23, 2025

Aptevo Therapeutics Inc.

Stockholders approved reverse split 1:6 to 1:20 at May 14 special meeting; board chose 1:20 on May 21.
Filed Certificate of Amendment effective 5:01 PM ET May 23; shares trade split-adjusted from May 27.
No fractional shares issued; cash payment in lieu for stockholders; warrants rounded up to whole share.
New CUSIP 03835L 504; par value remains $0.001 per share; adjustments to options, RSUs, warrants.
Reverse split reduces outstanding shares proportionately, no change in percentage ownership for stockholders.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.